Brook I
Arch Otolaryngol. 1984 Apr;110(4):228-31. doi: 10.1001/archotol.1984.00800300020004.
The presence of beta-lactamase-producing bacteria in clinical specimens was investigated in 185 children with orofacial or respiratory tract infections. All of these patients failed to respond to antimicrobial therapy, including penicillins, that was administered to 148 (80%) of them. beta-Lactamase-producing aerobic and anaerobic bacteria were detected in 75 (40.5%) of the 185 children. The beta-lactamase-producing strains included all 11 strains of the Bacteroides fragilis group, 30 (45.4%) of the 66 strains of Bacteroides melaninogenicus group, five (41.7%) of the 12 strains of Bacteroides oralis, and 41 (97.6%) of 42 strains of Staphylococcus aureus. All beta-lactamase-producing Bacteroides strains were resistant to penicillin as compared with the non-beta-lactamase-producing strains. Clinical cure was achieved after surgical drainage and a change in antimicrobial therapy in most of the patients. In treatment of orofacial and respiratory tract infections, the clinician should consider the presence of beta-lactamase-producing Bacteroides sp and S aureus as a possible cause of clinical failure with various penicillin therapies.
对185例患有口面部或呼吸道感染的儿童的临床标本中产β-内酰胺酶细菌的存在情况进行了调查。所有这些患者对抗菌治疗均无反应,其中148例(80%)接受了包括青霉素在内的抗菌治疗。在185名儿童中,有75名(40.5%)检测出产β-内酰胺酶的需氧菌和厌氧菌。产β-内酰胺酶的菌株包括脆弱拟杆菌群的所有11株菌株、产黑色素拟杆菌群66株菌株中的30株(45.4%)、口腔拟杆菌12株菌株中的5株(41.7%)以及金黄色葡萄球菌42株菌株中的41株(97.6%)。与不产β-内酰胺酶的菌株相比,所有产β-内酰胺酶的拟杆菌菌株均对青霉素耐药。大多数患者在手术引流和抗菌治疗改变后实现了临床治愈。在治疗口面部和呼吸道感染时,临床医生应考虑产β-内酰胺酶的拟杆菌属和金黄色葡萄球菌的存在可能是各种青霉素治疗临床失败的原因。